IL4 and allergic disease: This Th2-cell-like reprograming of Treg cells, that in allergy-susceptible mice is driven by IL-4 production by ILC2s and activated mast cells (56, 68), supports the interpretation that there is a generally dysfunctional Treg cell response in allergic patients.